Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itsuro Endo

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|July 12, 2025
Mean Corpuscular Volume Is Correlated with Liver Fibrosis Defined by Noninvasive Blood Biochemical Indices in Individuals with Metabolic Disorders Aged 60 Years or OlderYousuke Kaneko, Yutaka Kawano, Saki Kawata, et al.
Antioxidants (Basel, Switzerland)|January 21, 2023
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2Yoshiki Higa, Masahiro Hiasa, Hirofumi Tenshin, et al.
Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.
British Journal of Haematology|January 13, 2018
Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activityShiro Fujii, Shingen Nakamura, Asuka Oda, et al.
Oncotarget|September 15, 2016
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alterationRyota Amachi, Masahiro Hiasa, Jumpei Teramachi, et al.
Clinical & Translational Immunology|January 26, 2022
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expressionHirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, et al.
Oncotarget|March 15, 2018
Effective impairment of myeloma cells and their progenitors by hyperthermiaHirokazu Miki, Shingen Nakamura, Asuka Oda, et al.
Cancers|April 15, 2020
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of FebuxostatMohannad Ashtar, Hirofumi Tenshin, Jumpei Teramachi, et al.
International Journal of Hematology|January 21, 2024
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitorsKimiko Sogabe, Shingen Nakamura, Yoshiki Higa, et al.
Journal of Diabetes Investigation|April 9, 2022
Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNAAsami Okada, Misuzu Yamada-Yamashita, Yukari Tominaga, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|July 12, 2025
Mean Corpuscular Volume Is Correlated with Liver Fibrosis Defined by Noninvasive Blood Biochemical Indices in Individuals with Metabolic Disorders Aged 60 Years or OlderYousuke Kaneko, Yutaka Kawano, Saki Kawata, et al.
Antioxidants (Basel, Switzerland)|January 21, 2023
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2Yoshiki Higa, Masahiro Hiasa, Hirofumi Tenshin, et al.
Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.
British Journal of Haematology|January 13, 2018
Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activityShiro Fujii, Shingen Nakamura, Asuka Oda, et al.
Oncotarget|September 15, 2016
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alterationRyota Amachi, Masahiro Hiasa, Jumpei Teramachi, et al.
Clinical & Translational Immunology|January 26, 2022
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expressionHirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, et al.
Oncotarget|March 15, 2018
Effective impairment of myeloma cells and their progenitors by hyperthermiaHirokazu Miki, Shingen Nakamura, Asuka Oda, et al.
Cancers|April 15, 2020
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of FebuxostatMohannad Ashtar, Hirofumi Tenshin, Jumpei Teramachi, et al.
International Journal of Hematology|January 21, 2024
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitorsKimiko Sogabe, Shingen Nakamura, Yoshiki Higa, et al.
Journal of Diabetes Investigation|April 9, 2022
Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNAAsami Okada, Misuzu Yamada-Yamashita, Yukari Tominaga, et al.
Pageof 12